PNW PINNACLE WEST CAPITAL CORP
Price Chart
Executive Summary
Pinnacle West Capital Corporation filed a 424B5 prospectus supplement to continue its at-the-market (ATM) common stock offering program, refreshing the remaining $270 million of capacity under a $900 million aggregate gross sales price limit. The company has already sold approximately $630 million under the prior supplement. Proceeds will fund capital expenditures at its subsidiary APS, repay commercial paper, or for general corporate purposes. The filing is a routine administrative continuation of an existing equity distribution program and does not contain any new financial results or material business developments.
Actionable Insight
This is a continuation of an existing ATM program with no new pricing or financial data. Monitor the pace of share issuance and any forward sale agreement settlements for dilution impact. The proceeds are earmarked for capex and commercial paper repayment, which is credit-neutral for the utility. No immediate trading catalyst.
Key Facts
- Aggregate gross sales price of up to $900,000,000 under the equity distribution agreement.
- Approximately $630,000,000 already sold under the prior prospectus supplement; approximately $270,000,000 remains to be sold.
- Last reported sale price on June 4, 2026 was $100.48 per share.
- Net proceeds to be used for investment in APS to fund capital expenditures, repayment of commercial paper, or general corporate purposes.
- As of March 31, 2026, Pinnacle West had ~$103 million and APS had ~$316 million of outstanding commercial paper.
- Managers receive a commission of up to 1% of aggregate gross sales price.
- Forward sale agreements may be used, with settlement expected via physical delivery of shares within 2 to 24 months.
- Offering expenses estimated at approximately $500,000.
Financial Impact
Up to $270 million in additional common stock issuance at market prices, representing ~2.2% of market cap ($12.2B). Dilution to existing shareholders is modest and gradual.
Risk Factors
- Potential dilution from future share issuance under the ATM program.
- Forward sale agreements could result in accelerated physical settlement and dilution if stock loan costs rise or dividend thresholds are exceeded.
- Market price of common stock may decline due to the perception of ongoing equity sales.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001104659-26-071019 |
| Document: 0001104659-26-071019-index-headers.html | 0001104659-26-071019 |
| Document: 0001104659-26-071019-index.html | 0001104659-26-071019 |
| Document: 0001104659-26-071019.txt | 0001104659-26-071019 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
6d ago
|
8-K
| $101.30 awaiting T+5 | awaiting T+5 | — | $103.44 (+2.11%) |
|
Jun 5, 2026
9d ago
|
8-K
| $101.15 awaiting T+5 | awaiting T+5 | — | $103.44 (+2.26%) |
|
Jun 5, 2026
9d ago
|
424B5
| $103.09 awaiting T+5 | awaiting T+5 | — | $103.44 (+0.34%) |
|
Jun 1, 2026
13d ago
|
424B5
| $97.48 $103.06 | ▲ +5.72% | ▲ +8.47% | $103.44 (+6.11%) |
|
May 4, 2026
5w ago
|
8-K
| $101.82 $99.71 | ▼ −2.07% | ▼ −5.01% | $103.44 (+1.59%) |
|
Apr 15, 2026
8w ago
|
8-K
| $103.25 $103.45 | ▲ +0.19% | ▼ −0.79% | $103.44 (+0.18%) |
|
Apr 3, 2026
10w ago
|
DEFA14A
| $101.57 $102.63 | ▲ +1.04% | ▼ −3.09% | $103.44 (+1.84%) |
|
Feb 25, 2026
15w ago
|
8-K
| $98.91 $102.99 | ▲ +4.12% | ▲ +5.22% | $103.44 (+4.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access